Jenny Li
About Jenny Li
Jenny Li serves as the Vice President and Corporate Controller at Ligand Pharmaceuticals, where she has worked since 2021. She holds a Bachelor of Business Administration from Shanghai University of International Business and Economics and a Master's degree in Accounting from the University of Houston-Clear Lake.
Current Role at Ligand Pharmaceuticals
Jenny Li serves as the Vice President and Corporate Controller at Ligand Pharmaceuticals. She has held this position since 2021 and is based in San Diego, California. In her role, she oversees financial reporting, compliance, and accounting operations, ensuring that the company's financial practices align with regulatory standards and corporate objectives.
Previous Experience at Ligand Pharmaceuticals
Prior to her current role, Jenny Li worked at Ligand Pharmaceuticals as the Corporate Controller from 2020 to 2021. She also served as the Director of SEC Reporting and Technical Accounting from 2018 to 2020. During her tenure, she contributed to the company's financial reporting processes and compliance with SEC regulations.
Experience at AMN Healthcare
Jenny Li worked at AMN Healthcare for 13 years, from 2005 to 2018. During her time there, she held the positions of Director of Financial Reporting and Manager of Financial Reporting. Her responsibilities included managing financial reporting functions and ensuring the accuracy of financial statements.
Professional Background at Deloitte
Jenny Li began her career at Deloitte, where she worked as a Senior Accountant from 1997 to 2000. Her experience at Deloitte provided her with a strong foundation in accounting principles and practices, which she has applied throughout her career in various financial roles.
Education and Expertise
Jenny Li holds a Bachelor of Business Administration (B.B.A.) in International Business from Shanghai University of International Business and Economics. She also earned a Master's degree in Accounting from the University of Houston-Clear Lake. Her educational background supports her expertise in financial management and reporting.